Subscribe to Wyeth

The Lead

KV Pharma Names Former Wyeth Exec as Chairman

October 4, 2013 8:21 am | News | Comments

Specialty drugmaker KV Pharmaceuticals has named a former Wyeth Pharmaceuticals executive as chairman of its board of directors. Joseph Mahady previously served as president of Wyeth Pharmaceuticals, where he led the company's $20 billion global medicines business.

Former Pfizer/Wyeth Executive Joins Synthetic Biologics, Inc.

August 6, 2013 8:14 am | News | Comments

Synthetic Biologics, Inc., a developer of biologics focused on the prevention and treatment of...

SAC Affiliate Pays $600M to Settle Trading Charges

March 18, 2013 7:58 am | by SARAH SKIDMORE,AP Business Reporter | News | Comments

Two affiliates of SAC Capital Advisors, the hedge fund run by billionaire Steven Cohen, will pay...

Ex-Hedge Fund Manager Pleads Not Guilty in Pharmaceutical Insider Trading

January 4, 2013 3:04 am | by LARRY NEUMEISTER,Associated Press | News | Comments

NEW YORK (AP) — A former hedge fund portfolio manager charged with carrying out a record-setting...

View Sample

FREE Email Newsletter

No New Trial in Arkansas Woman's Drug Lawsuit

October 31, 2012 5:07 am | News | Comments

LITTLE ROCK, Ark. (AP) — A judge has rejected a request for a new trial for an Arkansas woman who sued pharmaceutical companies Wyeth and Upjohn over the drugmakers' hormone-therapy drugs.  

Parents Sue Pharma Company Over Baby's Heart Defect

October 5, 2012 4:09 am | News | Comments

BUTTE, Mont. (AP) — The parents of a baby born with a serious heart defect are suing a pharmaceutical company and their physician alleging an antidepressant the mother was taking caused the defect.  

Mead Johnson Gets Apology from China Agency

July 11, 2012 3:58 am | News | Comments

GLENVIEW, Ill. (AP) — Shares of Mead Johnson Nutrition Co. rebounded in premarket trading Wednesday after a Chinese agency conceded that invalid testing led to erroneous reports that vanillin had been found in baby formula from companies including Mead Johnson.  


Mylan Confirms First-to-File Patent Challenge Relating to Pristiq Tablets

June 28, 2012 4:07 am | News | Comments

Mylan Inc. today confirmed that the company has been sued by Pfizer Inc., Wyeth LLC, Wyeth Pharmaceuticals Inc., and PF Prism C.V. in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Desvenlafaxine Succinate Extended-release Tablets, 50 mg and 100 mg.

Former Becton Dickinson and Wyeth Executive Joins Merck

August 23, 2011 4:26 am | News | Comments

Merck has announced the appointment of Richard R. DeLuca Jr. as executive vice president and president, Merck Animal Health, effective September 15, 2011.

Pfizer Beats Views Despite Slight Profit Decline

February 1, 2011 3:53 am | News | Comments

NEW YORK (AP) — Pfizer Inc. said Tuesday its fourth-quarter profit nearly quadrupled from a year ago when it was weighed down by restructuring charges, as revenue rose 6 percent, thanks to the addition of products from fellow drugmaker Wyeth, acquired late in 2009.

Human Genome Sciences Picks ex-Wyeth CFO for Board(2)

January 21, 2011 3:38 am | News | Comments

Lupus drug developer Human Genome Sciences Inc. has appointed former Wyeth Chief Financial Officer Greg Norden to its board of directors.

2011 Industry Predictions

January 7, 2011 4:26 am | by Bikash Chatterjee, President and CTO, Pharmatech Associates | Articles | Comments

As we emerge into the New Year, it is as good a time as any to take stock of where we are as an industry and what we might expect in the months to come.   There can be no doubt that 2010 was a watershed year.


Oklahoma Joins Wyeth Drug Pricing Case

July 16, 2010 4:18 am | News | Comments

OKLAHOMA CITY (AP) — A federal judge in Massachusetts has granted Attorney General Drew Edmondson's request to intervene in a lawsuit against drug manufacturer Wyeth.

Pfizer Appoints Mikael Dolsten President of Worldwide Research and Development

May 26, 2010 5:11 am | News | Comments

Today, Pfizer Inc. named Mikael Dolsten, M.D., PhD, President of Pfizer Worldwide Research and Development, as the Company completes its integration of these functions following the Wyeth acquisition.

South Dakota Attorney General Wants to Join in Lawsuits Against Wyeth

May 13, 2010 5:04 am | News | Comments

PIERRE, S.D. (AP) — Attorney General Marty Jackley says South Dakota is seeking to join in two whistleblower lawsuits against the drugmaker Wyeth.  

Pfizer Profit Slides on Charges for Wyeth Purchase

May 4, 2010 5:10 am | News | Comments

NEW YORK (AP) — Pfizer Inc. has reported a huge jump in its first-quarter revenue, thanks to its giant acquisition of Wyeth last October, but charges from the deal weighed down net income.

Massachusetts Doctor Accused of Fraud by Faking Research

January 15, 2010 3:36 am | News | Comments

RODRIQUE NGOWI Associated Press Writer BOSTON (AP) — Federal prosecutors announced Thursday that


Schreiner MediPharm is Honored with the Wyeth GROWS Award for Continuous Improvement

December 15, 2009 5:54 am | News | Comments

Schreiner MediPharm, a Germany-based global provider of specialty pharmaceutical labeling solutions for over 50 years, was recently presented with Wyeth's “Global Recognition for Outstanding Wyeth Suppliers” (GROWS) Award at a ceremony in Munich, Germany.

Pfizer Extends Commitment to Help Unemployed Americans

December 10, 2009 3:29 am | News | Comments

Pfizer today announced it will extend its MAINTAIN™ (Medicines Assistance for Those who Are in Need) patient assistance program for an additional year, through December 31, 2010.

Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR(R)

December 8, 2009 3:34 am | News | Comments

Mylan Inc. today announced that its subsidiary Mylan Pharmaceuticals Inc. has enteredinto settlement and license agreements with Wyeth, now part of Pfizer,relating to Venlafaxine Hydrochloride (HCl) Extended Release (ER) Capsules,37.

Jury Awards $75M in Punitive Damages to Illinois Woman in Prempro Cancer Case

November 23, 2009 10:44 am | News | Comments

PHILADELPHIA — A jury in Philadelphia has ordered Wyeth Pharmaceuticals to pay a woman $75 million in punitive damages after finding a link between her breast cancer and a hormone-replacement drug. That's according to an attorney for the woman, Connie Barton.

Vaccines on Horizon for AIDS, Alzheimer's, herpes

November 18, 2009 3:54 am | News | Comments

LINDA A. JOHNSON AP Business Writer MARIETTA, Pa. (AP) — Malaria. Tuberculosis. Alzheimer's disease. AIDS. Pandemic flu. Genital herpes. Urinary tract infections. Grass allergies. Traveler's diarrhea. You name it, the pharmaceutical industry is working on a vaccine to prevent it.

Status of Pfizer and Wyeth Research Facilities

November 10, 2009 4:05 am | News | Comments

The Associated Press Pfizer Inc., which just acquired fellow drugmaker Wyeth, is closing six of the two companies' research sites and keeping open 14 others. Two Cambridge, Mass., sites will operate as one.

Pfizer Trimming Research Plants After Buying Wyeth

November 9, 2009 7:29 am | News | Comments

LINDA A. JOHNSON AP Business Writer TRENTON, N.J. (AP) — The world's biggest drugmaker said Monday it is closing six of its 20 research facilities, reorganizing and consolidating others, and cutting the jobs of roughly 15 percent of its scientists and support staff.

New Damages Trial for Wyeth in Arkansas Hormones Case

November 3, 2009 3:51 am | News | Comments

TOM PARSONS Associated Press Writer LITTLE ROCK, Ark. (AP) — Wyeth Pharmaceuticals will get a new trial to determine if the drugmaker should pay punitive damages to a woman who got breast cancer after taking hormone replacement therapy, a federal appeals court ruled Monday. The 8th U.S.

Merck's Buy of Schering-Plough Gets FTC Approval

October 30, 2009 4:51 am | News | Comments

NEW YORK (AP) — Merck & Co. and Schering-Plough Corp. said Thursday they have won merger approval from the Federal Trade Commission and antitrust regulators in Switzerland and Canada. Merck hopes to close its $41.1 billion acquisition of Schering-Plough Corp. before the end of the year.

The Future of Pharmaceutical Quality Systems: A Need For Action

October 28, 2009 5:35 am | Articles | Comments

Improvements to quality systems at pharmaceutical and medical device companies can result in lower operating and compliance risk, improved ability to successfully launch new products and higher profitability. The current state of quality systems at many pharmaceutical and medical device companies is one that demands attention.

European Union Approves Merck Takeover of Schering-Plough

October 26, 2009 5:01 am | News | Comments

RAF CASERT Associated Press Writer BRUSSELS (AP) — The European Union approved Merck & Co.'s proposed takeover of Schering-Plough, which would create the second-biggest global producer of prescription medicines.

Dr. Mahdi B. Fawzi Joins Warner Chilcott as President, Global Research and Development

October 21, 2009 4:29 am | News | Comments

Warner Chilcott plc announced today that Dr. Mahdi Fawzi has joined the company as President, Global Research and Development. He joins Warner Chilcott from Wyeth Pharmaceuticals, where he was responsible for directing global preclinical development activities. "Dr.

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.